08/11/2024  17:31:57 Var. -2.50 Volume Denaro17:40:00 Lettera17:40:00 Capitalizzazione di mercato Dividend Y. Rapporto P/E
240.50CHF -1.03% 1,047
Fatturato: 251,843.50
232.00Quantità in denaro: 70 244.50Quantità in lettera: 418 3.63 bill.CHF - 41.18

Descrizione business

Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioning itself as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative uses of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. The technology portfolio is built around active pharmaceutical ingredients (APIs) and performance chemicals and comprises hazardous reactions, low-temperature and high-pressure reactions as well as continuous processing.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Dr. Markus Blocher
Consiglio di amministrazione
Marlene Born, Karin Krause, Dr. Stephan Kirschbaum, Dr. Urs Brändli, Dr. Thomas Rosatzin, Dr. Robert Dahinden, Dr. Rolf Schaller
Consiglio di sorveglianza
Dr. Markus Blocher, Dr. Pierre-Alain Ruffieux, Dr. Bernhard Urwyler
 

Dati aziendali

Name: Dottikon ES Holding AG
Indirizzo: Hembrunnstrasse 17,CH-5605 Dottikon
Telefono: +41-56-616-8111
Fax: -
E-mail: info@dottikon.com
Internet: www.dottikon.com
Industria: Commodities
Settore: Chemicals
Sub settore: Chemicals, diversified
Fine dell'anno finanziario: 31/03
Flottante libero: 16.20%
Data dell'IPO: -

Rapporti con gli investitori

Name: Marlene Born
IR telefono: +41-56-616-8201
IR Fax: -
IR e-mail: investor-relations@d...kon.com investor-relations@dottikon.com

Principali azionisti

Markus Blocher
 
64.74%
Altri
 
19.96%
Peter Grogg
 
7.00%
Miriam Baumann
 
5.10%
UBS Fund Management AG
 
3.20%